After controlling for high levels of bacterial contamination in their lab and reagents, researchers detect microbial genetic material in plasma samples from healthy people and cancer patients.
In the largest effort to date to standardize performance metrics of the cancer diagnostic across products, researchers say the products can likely detect advanced tumors reliably, but early-stage malignancies would remain a challenge.
The Scientist’s Creative Services Team | Sep 24, 2020 | 1 min read
Chris Heger and Johan Skog will discuss exosomes, some of the latest diagnostic applications in the exosome field, and introduce Simple Western technology.
The liquid biopsy, which detects cell-free tumor DNA, spotted undiagnosed cancers in some women, but had a greater number of false positives and false negatives.
The agency fires off a letter to Pathway Genomics, telling the company that its new cancer detection test could harm the public and is not validated by science.
